The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I:
wherein A, Q, X
1
, X
2
, Y, R
1
, R
2
, R
3
, R
4
, R
4
′, R
5
, R
6
and R
6
′ are as described herein.